Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
Pakistan Journal of Biological Sciences
  Year: 2012 | Volume: 15 | Issue: 10 | Page No.: 469-476
DOI: 10.3923/pjbs.2012.469.476
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

A Randomized Controlled Clinical Trial Investigating the Effect of Calcium Supplement Plus Low-dose Aspirin on hs-CRP, Oxidative Stress and Insulin Resistance in Pregnant Women at Risk for Pre-eclampsia

Z. Asemi, M. Samimi, Z. Heidarzadeh, H. Khorrammian and Z. Tabassi

Abstract:
Increased levels of pro-inflammatory factors, markers of oxidative stress and insulin resistance during pregnancy have been associated with the development of pre-eclampsia. There is some evidence to suggest that calcium supplement and aspirin can reduce the risk of the disorder. To our knowledge, no reports are available indicating the effects of consumed calcium supplement plus aspirin on high sensitivity C-reactive protein (hs-CRP), oxidative stress parameters and insulin resistance in pregnant women at risk for pre-eclampsia. This study was designed to investigate the effects of consumed calcium supplement plus low-dose aspirin on hs-CRP, oxidative stress parameters and insulin resistance among Iranian pregnant women at risk for pre-eclampsia. This randomized single-blind controlled clinical trial was carried out among 42 pregnant women at risk for pre-eclampsia, primigravida, aged 18-40 year old who were carrying singleton pregnancy at their third trimester. Subjects were randomly assigned to received either the placebo (n = 22) or calcium supplement plus low-dose aspirin (n = 20) for 9 weeks. Calcium supplement plus low-dose aspirin were containing 500 mg carbonate calcium plus 80 mg aspirin. Fasting blood samples were taken at baseline and after 9 weeks intervention to measure serum hs-CRP, oxidative stress parameters including plasma Total Antioxidant Capacity (TAC) and Total Glutathione (GSH), Fasting Plasma Glucose (FPG), serum insulin and HOMA-IR score. Consumption of calcium supplement plus low-dose aspirin resulted in a significant difference serum hs-CRP levels as compared to the placebo (102.87 vs. 3227.75 ng mL-1, p = 0.01). Also, mean changes for plasma TAC (68.96 vs. -74.46 mmol L-1, p = 0.04) and total GSH levels (304.33 vs. -39.33 μmol L-1, p = 0.03) were significantly different between the two groups. No significant differences were found comparing calcium supplement plus low-dose aspirin and placebo in terms of their effects on FPG, serum insulin levels and HOMA-IR. Within-group differences in the placebo group revealed a significant increase in serum hs-CRP levels (3227.75 ng mL-1, p = 0.008) and marginally significant increase in plasma total GSH levels (304.33 μmol L-1, p = 0.07). In conclusion, consumption calcium supplement plus low-dose aspirin during pregnancy for 9 weeks in pregnant women at risk for pre-eclampsia resulted in a significant difference serum hs-CRP and increased levels of plasma TAC and total GSH as compared to the placebo group, but could not affect serum insulin levels and HOMA-IR score.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Insulin Resistance and Interleukin-1β During Normal Pregnancy
How to cite this article:

Z. Asemi, M. Samimi, Z. Heidarzadeh, H. Khorrammian and Z. Tabassi, 2012. A Randomized Controlled Clinical Trial Investigating the Effect of Calcium Supplement Plus Low-dose Aspirin on hs-CRP, Oxidative Stress and Insulin Resistance in Pregnant Women at Risk for Pre-eclampsia. Pakistan Journal of Biological Sciences, 15: 469-476.

DOI: 10.3923/pjbs.2012.469.476

URL: https://scialert.net/abstract/?doi=pjbs.2012.469.476

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 

Curve Bottom